A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.

Clinical trial NCT05335993 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05335993
Sponsor: CanariaBio Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Ovarian Cancer Recurrent Epithelial Cancer of Ovary Recurrent Epithelial Ovarian Cancer Recurrent Fallopian Tube Cancer Peritoneal Cancer Recurrent Carcinoma of Ovary Adenocarcinoma of Ovary

Start date: 2022-07-25
Primary completion: 2026-12-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.